Julie Berbis1, Céline Reggio2, Gérard Michel3,4, Pascal Chastagner5, Yves Bertrand6, Justyna Kanold7, Nicolas Sirvent8, Dominique Plantaz9, André Baruchel10, Marie-Dominique Tabone11, Floriane Garnier3, Marie-Pascale Lehucher-Michel3,2, Pascal Auquier3. 1. EA 3279 - Public Health, Chronic Diseases and Quality of Life - Research Unit, Aix-Marseille University, Marseille, 13284, France. Julie.Berbis@ap-hm.fr. 2. Occupational Medicine and Health Department, APHM, Groupe Hospitalier Timone, 13385, Marseille, France. 3. EA 3279 - Public Health, Chronic Diseases and Quality of Life - Research Unit, Aix-Marseille University, Marseille, 13284, France. 4. Department of Pediatric Hematology and Oncology, Timone Enfants Hospital and Aix-Marseille University, Marseille, France. 5. Department of Pediatric Onco-Haematology, Hôpital d'Enfants de Brabois, Vandoeuvre Les Nancy, France. 6. Department of Pediatric Hematology and Oncology, University Hospital of Lyon, Lyon, France. 7. Department of Pediatric Hematology and Oncology, CIC Inserm 501, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France. 8. Pediatric Hematology and Oncology Department, University Hospital, Montpellier, France. 9. Department of Pediatric Hematology-Oncology, University Hospital of Grenoble, Grenoble, France. 10. Department of Paediatric Onco-haematology, APHP, Saint Louis Hospital, Paris, France. 11. Department of Paediatric Onco-haematology, APHP, GHUEP, Armand Trousseau Hospital, Paris, 75012, France.
Abstract
PURPOSE: Our principal aim was to assess the occupational outcomes of French survivors of childhood leukemia, compared to national population. The secondary objective was to identify determinants linked with employment stability after childhood leukemia. METHODS: All survivors aged 15 and over enrolled in the French LEA Cohort (Childhood and Adolescent Leukemia) were included. Occupational data were self-reported. The occupational distributions expected in the cohort for each age range were established based on the distribution in France as reference, and comparisons between observed and expected distributions were performed. Logistic regression model was used to explore determinants of stability of survivors' employment. RESULTS: The questionnaire was completed by 845 eligible survivors (response rate 87.8 %), with a mean age of 22.3 ± 5.4 years and a mean follow-up duration of 14.3 ± 6.3 years. Among the 361 survivors currently in the labor market, 36 (10.0 %) were seeking a job, which is significantly lower than expected (19.3 %) compared to French population. Conversely, among those currently employed, the number of survivors in unstable employment (43.9 %) was significantly higher than expected (33.5 %). Younger age and higher number of late effects were risk factors for unstable employment. CONCLUSIONS: While the employment rate of the young French adult population of childhood leukemia survivors seems rather positive, access to a steady job appears to be compromised for some survivors. IMPLICATIONS FOR CANCER SURVIVORS: A strategy to better identify particular subgroups of survivors at greatest risk for difficulties in their professional achievement will help ensure the development of specific intervention strategies and support procedures.
PURPOSE: Our principal aim was to assess the occupational outcomes of French survivors of childhood leukemia, compared to national population. The secondary objective was to identify determinants linked with employment stability after childhood leukemia. METHODS: All survivors aged 15 and over enrolled in the French LEA Cohort (Childhood and Adolescent Leukemia) were included. Occupational data were self-reported. The occupational distributions expected in the cohort for each age range were established based on the distribution in France as reference, and comparisons between observed and expected distributions were performed. Logistic regression model was used to explore determinants of stability of survivors' employment. RESULTS: The questionnaire was completed by 845 eligible survivors (response rate 87.8 %), with a mean age of 22.3 ± 5.4 years and a mean follow-up duration of 14.3 ± 6.3 years. Among the 361 survivors currently in the labor market, 36 (10.0 %) were seeking a job, which is significantly lower than expected (19.3 %) compared to French population. Conversely, among those currently employed, the number of survivors in unstable employment (43.9 %) was significantly higher than expected (33.5 %). Younger age and higher number of late effects were risk factors for unstable employment. CONCLUSIONS: While the employment rate of the young French adult population of childhood leukemia survivors seems rather positive, access to a steady job appears to be compromised for some survivors. IMPLICATIONS FOR CANCER SURVIVORS: A strategy to better identify particular subgroups of survivors at greatest risk for difficulties in their professional achievement will help ensure the development of specific intervention strategies and support procedures.
Entities:
Keywords:
Adult survivors; Childhood leukemia survivors; Employment; Late effects; Stability of work contract
Authors: Claudia Allemani; Hannah K Weir; Helena Carreira; Rhea Harewood; Devon Spika; Xiao-Si Wang; Finian Bannon; Jane V Ahn; Christopher J Johnson; Audrey Bonaventure; Rafael Marcos-Gragera; Charles Stiller; Gulnar Azevedo e Silva; Wan-Qing Chen; Olufemi J Ogunbiyi; Bernard Rachet; Matthew J Soeberg; Hui You; Tomohiro Matsuda; Magdalena Bielska-Lasota; Hans Storm; Thomas C Tucker; Michel P Coleman Journal: Lancet Date: 2014-11-26 Impact factor: 79.321
Authors: Inga M R Jóhannsdóttir; Marianne J Hjermstad; Torbjørn Moum; Finn Wesenberg; Lars Hjorth; Henrik Schrøder; Päivi Lähteenmäki; Gudmundur Jónmundsson; Jon H Loge Journal: J Cancer Surviv Date: 2010-01-16 Impact factor: 4.442
Authors: Marina Servitzoglou; Danai Papadatou; Ioannis Tsiantis; Helen Vasilatou-Kosmidis Journal: Support Care Cancer Date: 2007-06-12 Impact factor: 3.603
Authors: Maria Lorenzi; Amy J McMillan; Linda S Siegel; Bruno D Zumbo; Victor Glickman; John J Spinelli; Karen J Goddard; Sheila L Pritchard; Paul C Rogers; Mary L McBride Journal: Cancer Date: 2009-05-15 Impact factor: 6.860
Authors: Jenny W Y Pang; Debra L Friedman; John A Whitton; Marilyn Stovall; Ann C Mertens; Leslie L Robison; Noel S Weiss Journal: Pediatr Blood Cancer Date: 2008-01 Impact factor: 3.838
Authors: Katie A Devine; Salome Christen; Renée L Mulder; Morven C Brown; Lisa M Ingerski; Luzius Mader; Emma J Potter; Charlotte Sleurs; Adrienne S Viola; Susanna Waern; Louis S Constine; Melissa M Hudson; Leontien C M Kremer; Roderick Skinner; Gisela Michel; Jordan Gilleland Marchak; Fiona S M Schulte Journal: Cancer Date: 2022-04-18 Impact factor: 6.921